Alexander Burges

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

Isabelle Ray‐Coquard, Patricia Pautier, Sandro Pignata et al. · New England Journal of Medicine · 2019 · 1.9K citations · Full text

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

Philipp Harter, Jalid Sehouli, Domenica Lorusso et al. · New England Journal of Medicine · 2019 · 571 citations · Full text

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

M. M. Heiss, P. Murawa, P. Koralewski et al. · International Journal of Cancer · 2010 · 547 citations · Full text

Tumor Biology, Medicine, Puncture-free Survival +12

Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial

Philipp Harter, Andreas du Bois, Maik Hahmann et al. · Annals of Surgical Oncology · 2006 · 415 citations

Gynecologic Surgery, Surgical Oncology, Gynecological Surgery +10

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

I. Ray-Coquard, Alexandra Léary, Sandro Pignata et al. · Annals of Oncology · 2023 · 299 citations · Full text